Introduction

John evans is the ceo of cambridge, massachusetts base beam therapeutics. The company was founded a little over three years ago develop several types of d and a base editing developed in david lew's lab at harvard university. As this matures and becomes closer to becoming a real thing, that might become an fda approved product, it's likely to generate a lot of fear and controversy in the public. And have you heard about d and a script? D and a script recently launched the first ever bench top enzomatic d and a printer which uses their proprietary ansomatic synthesis technology.